Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Researchers receive federal funding to rapidly repurpose FDA-approved drugs for COVID-19

Researchers at the University of Maryland School of Medicine will be partnering on an agreement funded by the federal government's Defense Advanced Research Projects Agency (DARPA) to rapidly test hundreds of drugs, approved and marketed for other conditions, to see whether any can be repurposed to prevent or treat COVID-19.

16 Jun 2020

Antidepressant fluoxetine (Prozac) suppresses replication of SARS-CoV-2

A study conducted by researchers at Julius-Maximilians-Universität Würzburg has shown that the antidepressant agent fluoxetine may be an effective drug for the early treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among at-risk groups.

16 Jun 2020

Antibody cocktail with potential to treat COVID-19 identified

Researchers at the University of Maryland School of Medicine (UMSOM) evaluated several human antibodies to determine the most potent combination to be mixed in a cocktail and used as a promising anti-viral therapy against the virus that causes COVID-19.

16 Jun 2020

22 nonprofit organizations funded to support the needs of families in response to COVID-19

Voices for Healthy Kids, an initiative of the American Heart Association -- the world's leading voluntary organization dedicated to a world of longer, healthier lives -- announced that 22 nonprofit organizations have been awarded COVID-19 Rapid Response Grants to support the needs of families in response to the pandemic.

16 Jun 2020

Depression linked with increased risk of heart disease, study finds

A new study co-led by Simon Fraser University health sciences professor Scott Lear provides further evidence of the link between depressive symptoms and an increased risk of heart disease and early death.

16 Jun 2020

Sending discharge letters to patients can make major difference to patient outcomes

Sending discharge letters to patients as well as their GPs when they leave hospital could make a substantial difference to patient outcomes, according to a new study by University of Warwick researchers.

16 Jun 2020

Researchers are strengthening the capacity to assess the risk of COVID-19 in Europe

As people in Europe emerge from COVID-19 lockdowns, a study has identified which countries have populations most at risk from the virus.

16 Jun 2020

Awareness campaign aims to alleviate unnecessary fears about calling 9-1-1 in pandemic

As new COVID-19 cases continue to rise in 22 states and strain emergency departments nationwide, the Centers for Disease Control and Prevention (CDC) Morbidity and Mortality Weekly Report (MMWR) suggest ER visits in April were down 42% across the country compared to the same period last year.

16 Jun 2020

Wealthy hospital taps small craft breweries for financial aid to buy masks, gloves

As Inova Health System sought donations in March to buy personal protective equipment for its staff to treat COVID-19, Zach Mote, a police officer turned brewer, came to their aid.

16 Jun 2020

Health experts link rise in Arizona COVID cases to end of stay-at-home order

With new daily coronavirus cases rising in at least two dozen states, an explosion of new infections in Arizona is stretching some hospitals and alarming public health experts who link the surge in cases to the state’s lifting of a stay-at-home order a month ago.

16 Jun 2020

Cascade Chemistry selected to help speed clinical testing of promising investigational drug for COVID-19

Cascade Chemistry, a leading contract research and manufacturing organization serving the pharmaceutical, materials, and chemical industries, today announced that it has been selected to produce the active pharmaceutical ingredient for clinical trial supplies of RBT-9, an investigational therapy entering a Phase 2 trial for the treatment of COVID-19 patients who are at high risk of deteriorating health due to age or comorbid conditions such as kidney or cardiovascular disease.

16 Jun 2020

Why improved pneumonia diagnosis is needed now more than ever

News-Medical speaks to Dr. William La Via about why improved pneumonia diagnosis is vital, especially in the wake of the COVID-19 pandemic.

16 Jun 2020

New mapping tool details SNAP policies related to food shopping during the pandemic

The complex food shopping patterns that financially insecure families employ have been upended by the COVID-19 crisis.

16 Jun 2020

Researchers call for policy reform in nursing support amid current pandemic

There are close to 28 million nurses around the world who comprise a global workforce that delivers about 90 percent of primary healthcare, including frontline response to the COVID-19 pandemic.

16 Jun 2020

Scientists develop self-assessment tool for evaluation and treatment of COVID-19

Of the more than 275,000 people worldwide who accessed a USC web-based COVID-19 patient self-assessment tool, only 20 percent reported severe symptoms requiring immediate medical attention, according to new research published in the Journal of General Internal Medicine.

16 Jun 2020

Study reports structure of enzyme activator for high pathogenic avian influenza

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing the current pandemic of COVID-19, is the focus of many investigators seeking to find an effective vaccine or therapeutic. Among the potential targets are various protease enzymes suspected of allowing the virus to gain entry to host cells and establish a successful infection.

16 Jun 2020

SARS-CoV-2 mutation reduces S1 shedding, increases infective potential

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the seventh coronavirus known to infect humans. SARS-CoV-2 emerged in the last month of 2019 in Wuhan, China, sparking off the ongoing COVID-19 pandemic. This virus enters the host cells through receptor binding and membrane fusion between the viral and host cell membrane.

16 Jun 2020

Pandemic News and Research

Further Reading

Researchers receive federal funding to rapidly repurpose FDA-approved drugs for COVID-19

Antidepressant fluoxetine (Prozac) suppresses replication of SARS-CoV-2

Antibody cocktail with potential to treat COVID-19 identified

22 nonprofit organizations funded to support the needs of families in response to COVID-19

Depression linked with increased risk of heart disease, study finds

Sending discharge letters to patients can make major difference to patient outcomes

Researchers are strengthening the capacity to assess the risk of COVID-19 in Europe

Awareness campaign aims to alleviate unnecessary fears about calling 9-1-1 in pandemic

Wealthy hospital taps small craft breweries for financial aid to buy masks, gloves

Health experts link rise in Arizona COVID cases to end of stay-at-home order

Cascade Chemistry selected to help speed clinical testing of promising investigational drug for COVID-19

Why improved pneumonia diagnosis is needed now more than ever

New mapping tool details SNAP policies related to food shopping during the pandemic

Researchers call for policy reform in nursing support amid current pandemic

Scientists develop self-assessment tool for evaluation and treatment of COVID-19

Study reports structure of enzyme activator for high pathogenic avian influenza

SARS-CoV-2 mutation reduces S1 shedding, increases infective potential

Oxytocin study may help treat a variety of psychiatric conditions

Antibody cocktail is being tested in human COVID-19 trials

Survey: Low income Vermonters have been disproportionately affected by COVID-19

Best practices - optimize qPCR processes for pathogen detection eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News